Preservative-Free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% for Treatment-Naive Patients with Open-Angle Glaucoma

CONCLUSIONS: In this real-world observational study, once-daily treatment with PF tafluprost/timolol FC demonstrated clinically relevant and statistically significant efficacy, as well as safety and good tolerability, in treatment-naive patients diagnosed with POAG.PMID:38665112 | DOI:10.3341/kjo.2024.0021
Source: Korean Journal of Ophthalmology : KJO - Category: Opthalmology Authors: Source Type: research